½ÃÀ庸°í¼­
»óǰÄÚµå
1702109

¼öÀÇ ¼­ºñ½º ½ÃÀå º¸°í¼­ : ¼­ºñ½ºº°, µ¿¹° À¯Çüº°, ÃÖÁ¾ ¿ëµµº°, Áö¿ªº°(2025-2033³â)

Veterinary Service Market Report by Service (Surgery, Diagnostic Tests and Imaging, Physical Health Monitoring, and Others), Animal Type (Companion Animal, Farm Animal), End Use (Veterinary Clinic, Veterinary Hospital), and Region 2025-2033

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: IMARC | ÆäÀÌÁö Á¤º¸: ¿µ¹® 143 Pages | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

IMARC GroupÀº ¼öÀÇ ¼­ºñ½º ¼¼°è ½ÃÀå ±Ô¸ð°¡ 2024³â 1,182¾ï ´Þ·¯¿¡ ´ÞÇßÀ¸¸ç, 2025-2033³â 4.3%ÀÇ ¿¬Æò±Õ ¼ºÀå·ü(CAGR)·Î 2033³â¿¡´Â 1,729¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøÇß½À´Ï´Ù. ½ÃÀåÀº ¹Ý·Áµ¿¹° »çÀ°·ü Áõ°¡, µ¿¹° °Ç°­¿¡ ´ëÇÑ Áö½Ä Çâ»ó, ±â¼ú °³¹ß·Î ÀÎÇØ Áö¼ÓÀûÀ¸·Î °³Ã´µÇ°í ÀÖÀ¸¸ç, ³ôÀº °¡Ã³ºÐ ¼Òµæ°ú ÀÎÇÁ¶óÀÇ ¼±Áø¼ºÀ¸·Î ÀÎÇØ ºÏ¹Ì°¡ ½ÃÀåÀ» ÁÖµµÇϰí ÀÖ½À´Ï´Ù.

¼öÀÇ ¼­ºñ½º´Â µ¿¹° Áúº´, Àμö°øÅëÀü¿°º´, ½ÄÁßµ¶ÀÇ °¨½Ã, Á¶±â Áø´Ü ¹× Ä¡·á¿¡ ÀÌ¿ëµË´Ï´Ù. µ¿¹° À¯·¡ ½Äǰ ³» µ¿¹°¿ëÀǾàǰÀÇ ÀÜ·ù ¹× Ç×±ÕÁ¦ ³»¼º(AMR) °³¹ß °ü·Ã ±ÔÁ¤ Áؼö À§¹Ý °¡´É¼ºÀ» ÃÖ¼ÒÈ­Çϱâ À§ÇØ Ç×±ÕÁ¦ µî µ¿¹°¿ëÀǾàǰ¿¡ ÀÇÁ¸Çϰí ÀÖ½À´Ï´Ù. ÀÌ¿Í ´õºÒ¾î ½Äǰ »ý»êÀÚ, °¡°ø¾÷ü, À¯Åë¾÷üÀÇ ÀνÄÀ» Á¦°íÇÏ¿© µ¿¹°¼º ½ÄǰÀÇ ¾ÈÀü¼ºÀ» È®º¸ÇÒ ¼ö ÀÖµµ·Ï Áö¿øÇÕ´Ï´Ù.

¼öÀÇ ¼­ºñ½º ½ÃÀå µ¿Çâ :

µ¿¹°¿¡¼­ À¯·¡ÇÑ Àΰ£ º´¿øÃ¼ÀÇ ¼ö°¡ Áõ°¡ÇÔ¿¡ µû¶ó µ¿¹° º¸È£, °øÁß º¸°Ç ¹× ½Äǰ ¾ÈÀüÀ» º¸ÀåÇϱâ À§ÇØ ¼öÀÇ ¼­ºñ½º°¡ Á¡Á¡ ´õ Áß¿äÇØÁö°í ÀÖ½À´Ï´Ù. ÀÌ´Â Àü ¼¼°èÀûÀ¸·Î ¹Ý·Áµ¿¹° »çÀ°ÀÌ Áõ°¡Çϰí ÀÖ´Â Ãß¼¼¿Í ¸Â¹°·Á ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÏ´Â Áß¿äÇÑ ¿äÀÎ Áß Çϳª°¡ µÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¸¹Àº ±¹°¡ÀÇ Á¤ºÎµéÀº Äڷγª¹ÙÀÌ·¯½º°¨¿°Áõ-19(COVID-19)ÀÇ ¹ß»ýÀ» ÀÌÀ¯·Î ¿ø°ÝÀÇ·á¿Í ¼öÀÇ»ç-ȯÀÚ °ü°è(VCPR)¿¡ ´ëÇÑ ±ÔÁ¦¸¦ ¿ÏÈ­ÇÏ¿© ¹Ý·Áµ¿¹° º¸È£ÀÚµéÀÌ ¿ø°ÝÀǷḦ ÀÌ¿ëÇÒ ¼ö ÀÖµµ·Ï Çã¿ëÇϰí ÀÖ½À´Ï´Ù. ¿ø°ÝÀÇ·á´Â ¼öÀÇÇп¡¼­ ¼ö¼ú ÈÄ Á¡°Ë, ÇǺΰúÀû ¹®Á¦, Çൿ ¹®Á¦, ¸¸¼ºÁúȯÀ» °¡Áø ¹Ý·Áµ¿¹°ÀÇ Á¤±âÀûÀÎ °æ°ú °üÂû µî¿¡ Ȱ¿ëµÇ°í ÀÖÀ¸¸ç, À̸¦ ÅëÇØ ¼öÀÇ»ç´Â ¹Ý·Áµ¿¹°À» Á÷Á¢ Áø·áÇÏÁö ¾Ê°íµµ Ä¡·á¸¦ ó¹æÇÒ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù. ÀÌ´Â ¿Â¶óÀÎ ¹Ý·Áµ¿¹° ¾à±¹, Á¤±â ±¸¸Å ¼­ºñ½º¸¦ ÅëÇÑ »ç·á ¹× Á¦Ç° ¹è¼Û µî ÃÖ±Ù ¹Ý·Áµ¿¹° ¼­ºñ½ºÀÇ È®´ë¿Í ÇÔ²² ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇϰí ÀÖ½À´Ï´Ù. À̿ʹ º°µµ·Î, Áúº´ ºÎ´ãÀ» ÃÖ¼ÒÈ­ÇÏ°í µ¿¹°ÀÇ °Ç°­°ú º¹Áö ¼öÁØÀ» Çâ»ó½Ã۱â À§ÇÑ ¹é½Å, Ç×±ÕÁ¦, Áø´Ü µµ±¸¿Í °°Àº µ¿¹° À§»ý ¹ÙÀÌ¿ÀÅ×Å©³î·¯ÁöÀÇ ¹ßÀüÀº ½ÃÀå¿¡ ±àÁ¤ÀûÀÎ ¿µÇâÀ» ¹ÌÄ¡°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, Ãà»ê ºÎ¹®ÀÇ °ý¸ñÇÒ ¸¸ÇÑ ¼ºÀåÀº ÇâÈÄ ¸î ³â µ¿¾È ½ÃÀå¿¡ ¹àÀº Àü¸ÁÀ» °¡Á®´Ù ÁÙ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

º» º¸°í¼­¿¡¼­ ´Ù·é ÁÖ¿ä Áú¹®

  • 2024³â ¼¼°è ¼öÀÇ ¼­ºñ½º ½ÃÀå ±Ô¸ð´Â?
  • 2025-2033³â ¼¼°è ¼öÀÇ ¼­ºñ½º ½ÃÀåÀÇ ¿¹»ó ¼ºÀå·üÀº?
  • ¼¼°è ¼öÀÇ ¼­ºñ½º ½ÃÀåÀ» À̲ô´Â ÁÖ¿ä ¿äÀÎÀº?
  • Äڷγª19°¡ ¼¼°è ¼öÀÇ ¼­ºñ½º ½ÃÀå¿¡ ¹ÌÄ¡´Â ¿µÇâÀº?
  • ¼¼°è ¼öÀÇ»ç ¼­ºñ½º ½ÃÀåÀÇ ¼­ºñ½ºº° ºÐ·ù´Â?
  • ¼¼°è ¼öÀÇ ¼­ºñ½º ½ÃÀåÀÇ µ¿¹° À¯Çüº° ºÐ·ù´Â?
  • ¼¼°è ¼öÀÇ ¼­ºñ½º ½ÃÀåÀÇ ÁÖ¿ä Áö¿ªÀº?
  • ¼¼°è ¼öÀÇ ¼­ºñ½º ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷Àº?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹üÀ§¿Í Á¶»ç ¹æ¹ý

  • Á¶»ç ¸ñÀû
  • ÀÌÇØ°ü°èÀÚ
  • µ¥ÀÌÅÍ ¼Ò½º
    • 1Â÷ Á¤º¸
    • 2Â÷ Á¤º¸
  • ½ÃÀå ÃßÁ¤
    • º¸ÅÒ¾÷ Á¢±Ù
    • Åé´Ù¿î Á¢±Ù
  • Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ¼­·Ð

  • °³¿ä
  • ÁÖ¿ä ¾÷°è µ¿Çâ

Á¦5Àå ¼¼°èÀÇ ¼öÀÇ ¼­ºñ½º ½ÃÀå

  • ½ÃÀå °³¿ä
  • ½ÃÀå ½ÇÀû
  • COVID-19ÀÇ ¿µÇâ
  • ½ÃÀå ¿¹Ãø

Á¦6Àå ½ÃÀå ºÐ¼® : ¼­ºñ½ºº°

  • ¼ö¼ú
  • Áø´Ü °Ë»ç ¹× ¿µ»ó Áø´Ü
  • ½Åü °Ç°­ ¸ð´ÏÅ͸µ
  • ±âŸ

Á¦7Àå ½ÃÀå ºÐ¼® : µ¿¹° À¯Çüº°

  • ¹Ý·Áµ¿¹°
  • ³óÀ嵿¹°

Á¦8Àå ½ÃÀå ºÐ¼® : ÃÖÁ¾ ¿ëµµº°

  • µ¿¹° Ŭ¸®´Ð
  • µ¿¹° º´¿ø

Á¦9Àå ½ÃÀå ºÐ¼® : Áö¿ªº°

  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • Áß±¹
    • ÀϺ»
    • Àεµ
    • Çѱ¹
    • È£ÁÖ
    • Àεµ³×½Ã¾Æ
    • ±âŸ
  • À¯·´
    • µ¶ÀÏ
    • ÇÁ¶û½º
    • ¿µ±¹
    • ÀÌÅ»¸®¾Æ
    • ½ºÆäÀÎ
    • ·¯½Ã¾Æ
    • ±âŸ
  • ¶óƾ¾Æ¸Þ¸®Ä«
    • ºê¶óÁú
    • ¸ß½ÃÄÚ
    • ±âŸ
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • ½ÃÀå ³»¿ª : ±¹°¡º°

Á¦10Àå SWOT ºÐ¼®

  • °³¿ä
  • °­Á¡
  • ¾àÁ¡
  • ±âȸ
  • À§Çù

Á¦11Àå ¹ë·ùüÀÎ ºÐ¼®

Á¦12Àå PorterÀÇ Five Forces ºÐ¼®

  • °³¿ä
  • ¹ÙÀ̾îÀÇ ±³¼··Â
  • °ø±Þ ±â¾÷ÀÇ ±³¼··Â
  • °æÀï Á¤µµ
  • ½Å±Ô ÁøÃâ¾÷üÀÇ À§Çù
  • ´ëüǰÀÇ À§Çù

Á¦13Àå °¡°Ý ºÐ¼®

Á¦14Àå °æÀï ±¸µµ

  • ½ÃÀå ±¸Á¶
  • ÁÖ¿ä ±â¾÷
  • ÁÖ¿ä ±â¾÷ °³¿ä
    • Addison Biological Laboratory Inc.
    • Armor Animal Health
    • CityVet
    • CVS Group PLC
    • Elanco Animal Health Incorporated
    • Ethos Veterinary Health LLC
    • FirstVet
    • Greencross Vets
    • Heska Corporation
    • Idexx Laboratories Inc.
    • Intervet Inc.(Merck & Co. Inc.)
    • PetIQ LLC
    • Pets at Home Group PLC
LSH 25.05.28

The global veterinary service market size reached USD 118.2 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 172.9 Billion by 2033, exhibiting a growth rate (CAGR) of 4.3% during 2025-2033. The market is constantly developing, driven by rising pet ownership, greater knowledge of animal health, and technological developments, with North America leading due to high disposable incomes and advanced infrastructure.

A veterinary service is utilized in the surveillance, early diagnosis, and treatment of animal diseases, zoonoses, and foodborne zoonotic hazards. It relies on veterinary medicinal products, such as antimicrobial agents, to minimize the likelihood of non-compliance concerning veterinary drug residues in food of animal origin and the development of antimicrobial resistance (AMR). Besides this, it assists in increasing awareness about food producers, processors and distributors, and addressing animal production food safety.

Veterinary Service Market Trends:

With the rising number of human pathogens originating in animals, veterinary services are presently becoming increasingly essential for protecting animals, safeguarding public health, and ensuring food safety. This, in confluence with the increasing adoption of companion animals around the world, represents one of the key factors stimulating the growth of the market. Moreover, governments of numerous countries are relaxing the telemedicine and veterinarian-client-patient relationship (VCPR) regulations on account of the coronavirus disease (COVID-19) outbreak and making telemedicine available to pet parents. It is utilized in veterinary for postoperative checks, dermatologic concerns, behavioral issues, and scheduled follow-up visits for pets with chronic diseases, thereby allowing veterinarians to prescribe the treatment without the direct examination of pets. This, coupled with recent expansions in pet services, including online pet pharmacies and food and product delivery via subscription services, is impelling the market growth. Apart from this, advances in animal health biotechnologies, such as vaccines, antimicrobials, and diagnostic tools, for minimizing the burden of diseases and improving the standards of animal health and welfare are positively influencing the market. In addition, significant growth in the livestock sector is projected to create a positive outlook for the market in the upcoming years.

Key Market Segmentation:

Breakup by Service:

  • Surgery
  • Diagnostic Tests and Imaging
  • Physical Health Monitoring
  • Others

Breakup by Animal Type:

  • Companion Animal
  • Farm Animal

Breakup by End Use:

  • Veterinary Clinic
  • Veterinary Hospital

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Addison Biological Laboratory Inc., Armor Animal Health, CityVet, CVS Group PLC, Elanco Animal Health Incorporated, Ethos Veterinary Health LLC, FirstVet, Greencross Vets, Heska Corporation, Idexx Laboratories Inc., Intervet Inc. (Merck & Co. Inc.), PetIQ LLC and Pets at Home Group PLC.

Key Questions Answered in This Report

  • 1.What was the size of the global veterinary service market in 2024?
  • 2.What is the expected growth rate of the global veterinary service market during 2025-2033?
  • 3.What are the key factors driving the global veterinary service market?
  • 4.What has been the impact of COVID-19 on the global veterinary service market?
  • 5.What is the breakup of the global veterinary service market based on the service?
  • 6.What is the breakup of the global veterinary service market based on the animal type?
  • 7.What are the key regions in the global veterinary service market?
  • 8.Who are the key players/companies in the global veterinary service market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Veterinary Service Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Service

  • 6.1 Surgery
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Diagnostic Tests and Imaging
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Physical Health Monitoring
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Others
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Animal Type

  • 7.1 Companion Animal
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Farm Animal
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by End Use

  • 8.1 Veterinary Clinic
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Veterinary Hospital
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Addison Biological Laboratory Inc.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
    • 14.3.2 Armor Animal Health
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 CityVet
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
    • 14.3.4 CVS Group PLC
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
    • 14.3.5 Elanco Animal Health Incorporated
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
    • 14.3.6 Ethos Veterinary Health LLC
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
    • 14.3.7 FirstVet
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
    • 14.3.8 Greencross Vets
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
    • 14.3.9 Heska Corporation
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 Idexx Laboratories Inc.
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis
    • 14.3.11 Intervet Inc. (Merck & Co. Inc.)
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
    • 14.3.12 PetIQ LLC
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
      • 14.3.12.3 Financials
    • 14.3.13 Pets at Home Group PLC
      • 14.3.13.1 Company Overview
      • 14.3.13.2 Product Portfolio
      • 14.3.13.3 Financials
      • 14.3.13.4 SWOT Analysis
»ùÇà ¿äû ¸ñ·Ï
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
¸ñ·Ï º¸±â
Àüü»èÁ¦